Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open-label Exploratory Trial

NCT03342573 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03342573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03342573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open-label Exploratory Trial
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2018
Completion date
February 1, 2022
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pityriasis rubra pilaris